FDA inspection
Lonza Guangzhou Pharmaceutical Ltd.: FDA inspection ending Dec 14, 2018
FDA inspection 1077023 · No Action Indicated (NAI) · Guangzhou
Key facts
| Inspection ID | 1077023 |
|---|---|
| Firm | Lonza Guangzhou Pharmaceutical Ltd. |
| FEI number | 3006532186 |
| Address | 68 Huangge Dadaobei Aozhou Jie Si Xiang, Fanyu |
| City | Guangzhou |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Dec 14, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data